![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, February 12, 2012 8:57:43 PM
A July 29, 2011 press release stated that Optimedical had placed their third order with SurgLine and that "Optimedical is currently at a seven figure annual run rate with SurgLine and we expect the relationship to grow substantially as we continue to convert more of our customers." This alleged "seven figure annual run rate" is not mentioned in the 10-K or 10-Q and does not accord with SurgLine's total sales from March 16, 2011 (inception) to October 31, 2011 of $75,272. The July 29, 2011 press release is clearly a fraud and shareholders that purchased stock based on this press release and have suffered a loss may be entitled to both punitive and compensatory damages. No matter the monetary size of the loss, if the loss occurred because of this press release, you should contact your attorney immediately. If you don’t have an attorney, please contact us at submit@abuseoflaw.org and we attempt to assist you.
However, if you bought IDTA shares after the "Caveat Emptor" status was declared, damages may not be possible. "Hey, we warned you not to buy this junk. So sorry."
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM